Osteoporosis: The role of genetics and the environment

Forum of Nutrition

Volumn 60, Issue , 2007, Pages 158-167

  Ongphiphadhanakul, Boonsong ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

CONFERENCE PAPER; ENVIRONMENT; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; HUMAN; METABOLISM; OSTEOPOROSIS;

ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OSTEOPOROSIS; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN; VARIATION (GENETICS);

EID: 34547967995     PISSN: 16600347     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000107166     Document Type: Conference Paper

References (52)

1. Sowers MR, Burns TL, Wallace RB: Familial resemblance of bone mass in adult women. Genet Epidemiol 1986;3:85-93.
2. Lutz J: Bone mineral, serum calcium, and dietary intakes of mother/daughter pairs. Am J Clin Nutr 1986;44:99-106.
3. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S: Genetic determinants of bone mass in adults: a twin study. J Clin Invest 1987;80:706-710.
4. Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnston CC Jr: Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res 1991;6:561-567.
5. Deng HW, Chen WM, Conway T, Zhou Y, Davies KM, Stegman MR, Deng H, Recker RR: Determination of bone mineral density of the hip and spine in human pedigrees by genetic and life-style factors. Genet Epidemiol 2000;19:160-177.
6. Ferrari S, Rizzoli R, Slosman D, Bonjour JP: Familial resemblance for bone mineral mass is expressed before puberty. J Clin Endocrinol Metab 1998;83:358-361.
7. Gueguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G: Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 1995; 10: 2017-2022.
8. Sowers MR, Boehnke M, Jannausch ML, Crutchfield M, Corton G, Burns TL: Familiality and partitioning the variability of femoral bone mineral density in women of child-bearing age. Calcif Tissue Int 1992;50:110-114.
9. Niu T, Chen C, Cordell H, Yang J, Wang B, Wang Z, Fang Z, Schork NJ, Rosen CJ, Xu X: A genome-wide scan for loci linked to forearm bone mineral density. Hum Genet 1999; 104: 226-233.
10. Koller DL, Econs MJ, Morin PA, Christian JC, Hui SL, Parry P, Curran ME, Rodriguez LA, Conneally PM, Joslyn G, Peacock M, Johnston CC, Foroud T: Genome screen for QTLs contributing to normal variation in bone mineral density and osteoporosis. J Clin Endocrinol Metab 2000;85:3116-3120.
11. Gong G, Stern HS, Cheng SC, Fong N, Mordeson J, Deng HW, Recher RR: The association of bone mineral density with vitamin D receptor gene polymorphisms. Osteoporos Int 1999;9:55-64.
12. Thakkinstian A, D'Este C, Eisman J, Nguyen T, Attia J: Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res 2004;19:419-428.
13. Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH: Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet 1996;14:203-205.
14. Mann V, HobsonEE, Li B, Stewart TL, Grant SF, Robins SP, Aspden RM, Ralston SH: A COLIA1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 2001;107:899-907.
15. Efstathiadou Z, Tsatsoulis A, Ioannidis JP: Association of collagen Ialpha 1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysis, J Bone Miner Res 2001;16:1586-1592.
16. Ioannidis JP, Stavrou I, Trikalinos TA, Zois C, Brandi ML, Gennari L, Albagha O, Ralston SH, Tsatsoulis A; ER-alpha Genetics Meta-Analysis: Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis, J Bone Miner Res 2002;17:2048-2060.
17. Ferrari SL, Deutsch S, Choudhury U, Chevalley T, Bonjour JP, Dermitzakis ET, Rizzoli R, Antonarakis SE: Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet 2004;74:866-875.
18. Bollerslev J, Wilson SG, Dick IM, Islam FM, Ueland T, Palmer L, Devine A, Prince RL: LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. Bone 2005;36:599-606.
19. Koller DL, Ichikawa S, Johnson ML, Lai D, Xuei X, Edenberg HJ, Conneally PM, Hui SL, Johnston CC, Peacock M, Foroud T, Econs MJ: Contribution of the LRP5 gene to normal variation in peak BMD in women. J Bone Miner Res 2005;20:75-80.
20. Zhang ZL, Qin YJ, He JW, Huang QR, Li M, Hu YQ, Liu YJ: Association of polymorphisms in low-density lipoprotein receptor-related protein 5 gene with bone mineral density in post-menopausal Chinese women. Acta Pharmacol Sin 2005;26:1111-1116.
21. Urano T, Shiraki M, Ezura Y, Fujita M, Sekine E, Hoshino S, Hosoi T, Orimo H, Emi M, Ouchi Y, Inoue S: Association of a single-nucleotide polymorphism in low-density lipoprotein receptorrelated protein 5 gene with bone mineral density. J Bone Miner Metab 2004;22:341-345.
22. Koh JM, Jung MH, Hong JS, Park HJ, Chang JS, Shin HD, Kim SY, Kim GS: Association between bone mineral density and LDL receptor-related protein 5 gene polymorphisms in young Korean men. J Korean Med Sci 2004;19:407-412.
23. Recker RR, Deng HW: Role of genetics in osteoporosis. Endocrine 2002;17:55-66.
24. Deng HW, Shen H, Xu FH, et al: Tests of linkage and/or association of genes for vitamin D receptor, osteocalcin, and parathyroid hormone with bone mineral density. J Bone Miner Res 2002;17: 678-686.
25. Deng HW, Mahaney MC, Williams JT, et al: Relevance of the genes for bone mass variation to susceptibility to osteoporotic fractures and its implications to gene search for complex human diseases. Genet Epidemiol 2002;22:12-25.
26. Efstathiadou Z, Tsatsoulis A, Loannidis JP: Association of collagen 1 alpha 1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysis. J Bone Miner Res 2001;16:1586-1592.
27. Uitterlinden AG, Burger H, Huang Q, Yue F, McGuigan FE, Grant SF, Hofman A, van Leeuwen JP, Pols HA, Ralston SH: Relation of alleles of the collagen type Ialphal gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med. 1998;338: 1016-1021.
28. Garnero P, Borel O, Grant SF, Ralston SH, Delmas PD: Collagen Ialphal Sp1 polymorphism, bone mass, and bone turnover in healthy French premenopausal women: the OFELY study. J Bone Miner Res 1998;13:813-817.
29. Han KO, Moon IG, Hwang CS, Choi JT, Yoon HK, Min HK, Han IK: Lack of an intronic Sp1 binding-site polymorphism at the collagen type I alpha1 gene in healthy Korean women. Bone 1999;24:135-137.
30. Nakajima T, Ota N, Shirai Y, Hata A, Yoshida H, Suzuki T, Hosoi T, Orimo H, Emi M: Ethnic difference in contribution of Sp1 site variation of COLIA1 gene in genetic predisposition to osteoporosis. Calcif Tissue Int 1999;65:352-353.
31. Lambrinoudaki I, Kung AW: Absence of high-risk V allele associated with osteoporosis at the intronic SP1 binding-site of collagen I alpha1 gene in Southern Chinese. J Endocrinol Invest 2001;24:499-502.
32. Johnston CC Jr, Miller JZ, Slemenda CE, Reister TK, Hui S, Christian JC, Peacock M: Calcium supplementation and increases in bone mineral density in children, N Engl J Med 1992;327: 82-87.
33. Nowson CA, Green RM, Hopper JL, Sherwin AJ, Young D, Kaymakci B, Guest CS, Smid M, Larkins RG, Wark JD: A co-twin study of the effect of calcium supplementation on bone density during adolescence. Osteoporos Int 1997;7:219-225.
34. Chevalley T, Rizzoli R, Hans D, Ferrari S, Bonjour JP: Interaction between calcium intake and menarcheal age on bone mass gain: an eight-year follow-up study from prepuberty to postmenarche. J Clin Endocrinol Metab 2005;90:44-51.
35. Matkovic V, Goel PK, Badenhop-Stevens NE, Landoll JD, Li B, Llich JZ, Skugor M, Nagode LA, Mobley SL, Ha EJ, Hangartner TN, Clairmont A: Calcium supplementation and bone mineral density in females from childhood to young adulthood: a randomized controlled trial. Am J Clin Nutr 2005;81:175-188.
36. Welten DC, Kemper HC, Post GB, van Staveren WA: A meta-analysis of the effect of calcium intake on bone mass in young and middle aged, females and males. J Nutr 1995:125: 2802-2813.
37. Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L, Ortiz Z, Peterson J, Adachi J, Tugwell P, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group: Meta-analyses of therapies for postmenopausal osteoporosis. 7. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 2002;23: 552-559.
38. Dawson-Hughes B, Harris SS, Finneran S: Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 1995;80:3657-3661.
39. Morrison NA, George PM, Vaughan T, Tilyard MW, Frampton CM, Gilchrist NL: Vitamin D receptor genotypes influence the success of calcitriol therapy for recurrent vertebral fracture in osteoporosis. Pharmacogenet Genomics 2005;15:127-135.
40. Ongphiphadhanakul B, Chanprasertyothin S, Payattikul P, et al: Association of a T262C transition in exon 1 of estrogen-receptor-alpha gene with skeletal responsiveness to estrogen in post-menopausal women. J Endocrinol Invest 2001;24:749-755.
41. Ongphiphadhanakul B, Chanprasertyothin S, Payatikul P, et al: Oestrogen-receptor-alpha gene polymorphism affects response in bone mineral density to oestrogen in post-menopausal women. Clin Endocrinol (Oxf) 2000;52:581-585.
42. Salmen T, Heikkinen AM, Mahonen A, Kroger H, Komulainen M, Saarikoski S, Honkanen R, Maenpaa PH: The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women. J Bone Miner Res 2000; 15 : 2479-2486.
43. Han KO, Moon IG, Kang YS, Chung HY, Min HK, Han IK: Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. J Clin Endocrinol Metab 1997;82:991-995.
44. Herrington DM, Howard TD, Hawkins GA, et al: Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 2002;346:967-974.
45. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG: Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med. 2004;350: 2033-2041.
46. McLean RR, Jacques PF, Selhub J, Tucker KL. Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP: Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004;350:2042-2049.
47. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K: Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 2005;293:1082-1088.
48. Miyao M, Morita H, Hosoi T, Kurihara H, Inoue S, Hoshino S, Shiraki M, Yazaki Y, Ouchi Y: Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int 2000;66:190-194.
49. Jorgensen HL, Madsen JS, Madsen B, Saleh MM, Abrahamsen B, Fenger M, Lauritzen JB: Association of a common allelic polymorphism (C677T) in the methylenetetrahydrofolate reduc-tase gene with a reduced risk of osteoporotic fractures. A case control study in Danish post-menopausal women. Calcif Tissue Int 2002;71:386-392.
50. Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, Brixen K, Mosekilde L: A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. J Bone Miner Res 2003;18:723-729.
51. McLean RR, Karasik D, Selhub J, Tucker KL, Ordovas JM, Russo GT, Cupples LA, Jacques PF, Kiel DP: Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J Bone Miner Res 2004;19:410-418.
52. Macdonald HM, McGuigan FE, Fraser WD, New SA, Ralston SH, Reid DM: Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density. Bone 2004;35:957-964.